Overview

Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

Status:
Withdrawn

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

This study is a randomized, open-label, controlled study that will explore the efficacy of individualized adjuvant chemotherapy based on the adenosine triphosphate tumor chemosensitivity assay for patients with hepatocellular carcinoma after liver transplantation.

Phase:

Phase 2

Details

Lead Sponsor:

Zhejiang University

Treatments:

Adenosine
Fluorouracil
Oxaliplatin